The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 228 (1-2) , 257-266
- https://doi.org/10.1016/j.canlet.2004.12.054
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of ageCancer Letters, 2003
- Methods for categorizing a prognostic variable in a multivariable settingStatistics in Medicine, 2003
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1996
- Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group resultsEuropean Journal Of Cancer, 1995
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- A surgical perspective on the current staging in neuroblastoma— The international neuroblastoma staging system proposalJournal of Pediatric Surgery, 1989
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958